← All Ampio Pharmaceuticals, INC filings

Ampio Pharmaceuticals, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
AMPE
Ampio Pharmaceuticals, INC
10-K: Ampio Pharmaceuticals to Delist from NYSE American Amidst Program Halt and Liquidation Plans
Ampio Pharmaceuticals will voluntarily delist from the NYSE American and wind down operations after disappointing non-clinical trial results for its lead drug candidate, OA-201.